Amgros I/S is a partnership representing five regions in Denmark. They are seeking to establish framework agreements for the pharmaceuticals listed in the individual subcontracts below. The purpose is to supply the hospitals' pharmacies in these regions with medications, and potentially for resale t
Contract awarded. Originally published 6 months ago.
This contract opportunity is a re-tender of the previous sub-agreement for consulting services related to the ATMP Denmark program. The initial tender was canceled because the received bids did not meet the actual needs of Amgros. This tender involves awarding a framework agreement for consulting as
Amgros I/S (Amgros) is a partnership with the five regions as stakeholders. Amgros aims to establish framework agreements for the pharmaceuticals listed in the individual subcontracts below, to supply the stakeholders' hospital pharmacies with medications and potentially for resale to the Faroe Isla
Amgros I/S is a partnership involving five regions in Denmark. They are seeking to establish framework agreements for the pharmaceuticals listed in the individual subcontracts below. The purpose is to supply the hospital pharmacies of the stakeholders with medications, and potentially for resale to
The Hospital Pharmacy of Region North Denmark is seeking a new Quality Management System (QMS) to enhance its operations. This system should integrate document management and training with essential quality processes, including deviation management, CAPA (Corrective and Preventive Actions) managemen
St. James's Hospital is contracting outsourced breast imaging services with qualified medical imaging providers in Ireland.
North West London Pathology seeks a managed service partner to deliver integrated laboratory premises, equipment, and facilities management through a volume-based pricing model with risk and reward sharing over 14 years.
Competitive tender to deliver community-based minor surgery services in Newham, including skin procedures, joint injections, and cryotherapy, with a 2-year initial contract worth up to £1.3 million.
Qualified laboratories are sought to deliver pharmacogenomic testing for 4,854 patients across Northern Ireland and Ireland to optimize medicines prescribing in primary care.
